Insider · CIK 0001852018
William Conkling
ceoofficerdirector
Files at CYTH (Cyclo Therapeutics, Inc.), RFL (Rafael Holdings, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 21, 2025 | RFL Rafael Holdings, Inc. | FTax withholding Class B Common Stock, par value $.01 per share | -14,814 | $1.93 | $29k | 537,001 | Mar 25, 2025 |
| Feb 27, 2025 | CYTH Cyclo Therapeutics, Inc. | AGrant or award Common Stock | +27,654 | $0.00 | $0 | 77,884 | Mar 3, 2025 |
| Jan 13, 2025 | RFL Rafael Holdings, Inc. | AGrant or award Class B Common Stock, par value $.01 per share | +60,000 | $1.95 | $117k | 551,815 | Jan 15, 2025 |
| Dec 21, 2024 | RFL Rafael Holdings, Inc. | FTax withholding Class B Common Stock, par value $.01 per share | -12,807 | $1.84 | $24k | 491,815 | Dec 23, 2024 |
| Nov 15, 2024 | CYTH Cyclo Therapeutics, Inc. | AGrant or award Common Stock | +16,660 | $0.00 | $0 | 50,230 | Nov 18, 2024 |
| Oct 25, 2024 | RFL Rafael Holdings, Inc. | FTax withholding Class B Common Stock, par value $.01 per share | -3,431 | $1.84 | $6,313 | 504,622 | Oct 29, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.